Min Feng

Title: Min Feng: Innovator in Cancer Risk Identification and Treatment

Introduction

Min Feng is a notable inventor based in Singapore, recognized for his contributions to the field of cancer research. He has developed a significant patent that focuses on identifying the risk of cancer in human subjects. His innovative approach has the potential to enhance cancer diagnosis and treatment options.

Latest Patents

Min Feng holds a patent titled "Method of identifying risk of cancer and therapeutic options." This patent outlines a method for determining the risk of cancer by analyzing biological samples for copy number amplification of specific genomic regions on human chromosome 1q21. The presence of this amplification indicates an elevated risk of cancer. Furthermore, the patent describes therapeutic methods for treating cancer in subjects identified with this genetic marker, including the administration of agents that suppress IRAK1, IRAK4, or members of the S100 family, such as Pacritinib.

Career Highlights

Throughout his career, Min Feng has worked with esteemed organizations, including the Agency for Science, Technology and Research and Tan Tock Seng Hospital Pte Ltd. His work in these institutions has allowed him to contribute significantly to cancer research and therapeutic development.

Collaborations

Min Feng has collaborated with notable colleagues, including Qiang Yu and Jian Yuan Goh. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer treatment.

Conclusion

Min Feng's innovative work in identifying cancer risk and developing therapeutic options showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patent represents a significant step forward in cancer research.